SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-064484
Filing Date
2024-05-23
Accepted
2024-05-23 06:20:41
Documents
19
Period of Report
2024-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2415080d1_8k.htm   iXBRL 8-K 36154
2 EXHIBIT 3.1 tm2415080d1_ex3-1.htm EX-3.1 9577
3 EXHIBIT 5.1 tm2415080d1_ex5-1.htm EX-5.1 11773
4 EXHIBIT 10.1 tm2415080d1_ex10-1.htm EX-10.1 18387
5 EXHIBIT 99.1 tm2415080d1_ex99-1.htm EX-99.1 11943
9 GRAPHIC tm2415080d1_ex5-1img001.jpg GRAPHIC 6624
10 GRAPHIC tm2415080d1_ex99-1img001.jpg GRAPHIC 12661
  Complete submission text file 0001104659-24-064484.txt   309794

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA jagx-20240517.xsd EX-101.SCH 3045
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20240517_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20240517_pre.xml EX-101.PRE 22379
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2415080d1_8k_htm.xml XML 3799
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 24975141
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)